Agilent Technologies ROE 2010-2025 | A
Current and historical return on equity (ROE) values for Agilent Technologies (A) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Agilent Technologies ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-01-31 | $1.26B | $6.03B | 20.95% |
| 2024-10-31 | $1.29B | $5.90B | 21.30% |
| 2024-07-31 | $1.41B | $5.90B | 23.40% |
| 2024-04-30 | $1.24B | $6.21B | 20.87% |
| 2024-01-31 | $1.24B | $6.19B | 21.15% |
| 2023-10-31 | $1.24B | $5.85B | 21.76% |
| 2023-07-31 | $1.13B | $5.56B | 20.37% |
| 2023-04-30 | $1.35B | $5.78B | 24.80% |
| 2023-01-31 | $1.32B | $5.61B | 25.05% |
| 2022-10-31 | $1.25B | $5.31B | 24.26% |
| 2022-07-31 | $1.33B | $5.09B | 25.59% |
| 2022-04-30 | $1.26B | $5.12B | 24.51% |
| 2022-01-31 | $1.21B | $5.15B | 23.75% |
| 2021-10-31 | $1.21B | $5.39B | 24.26% |
| 2021-07-31 | $0.99B | $4.95B | 20.38% |
| 2021-04-30 | $0.93B | $4.81B | 19.01% |
| 2021-01-31 | $0.81B | $4.80B | 16.68% |
| 2020-10-31 | $0.72B | $4.87B | 14.77% |
| 2020-07-31 | $0.69B | $4.98B | 14.29% |
| 2020-04-30 | $0.68B | $4.77B | 14.30% |
| 2020-01-31 | $0.76B | $4.85B | 15.70% |
| 2019-10-31 | $1.07B | $4.75B | 21.79% |
| 2019-07-31 | $1.07B | $4.75B | 22.01% |
| 2019-04-30 | $1.12B | $5.13B | 23.15% |
| 2019-01-31 | $1.14B | $5.04B | 24.27% |
| 2018-10-31 | $0.32B | $4.57B | 6.91% |
| 2018-07-31 | $0.30B | $4.57B | 6.43% |
| 2018-04-30 | $0.24B | $4.62B | 5.10% |
| 2018-01-31 | $0.20B | $4.53B | 4.27% |
| 2017-10-31 | $0.68B | $4.84B | 15.10% |
| 2017-07-31 | $0.63B | $4.61B | 14.44% |
| 2017-04-30 | $0.58B | $4.38B | 13.48% |
| 2017-01-31 | $0.51B | $4.30B | 11.94% |
| 2016-10-31 | $0.46B | $4.25B | 11.00% |
| 2016-07-31 | $0.48B | $4.35B | 11.38% |
| 2016-04-30 | $0.46B | $4.17B | 11.23% |
| 2016-01-31 | $0.46B | $4.05B | 11.14% |
| 2015-10-31 | $0.40B | $4.17B | 9.62% |
| 2015-07-31 | $0.28B | $4.11B | 6.22% |
| 2015-04-30 | $0.31B | $4.16B | 6.47% |
| 2015-01-31 | $0.37B | $4.24B | 7.01% |
| 2014-10-31 | $0.50B | $5.30B | 9.03% |
| 2014-07-31 | $0.69B | $5.64B | 12.58% |
| 2014-04-30 | $0.71B | $5.63B | 13.48% |
| 2014-01-31 | $0.74B | $5.45B | 14.21% |
| 2013-10-31 | $0.72B | $5.29B | 13.96% |
| 2013-07-31 | $0.94B | $4.79B | 18.18% |
| 2013-04-30 | $1.01B | $5.31B | 19.56% |
| 2013-01-31 | $1.10B | $5.35B | 21.89% |
| 2012-10-31 | $1.15B | $5.19B | 23.92% |
| 2012-07-31 | $1.02B | $4.87B | 22.09% |
| 2012-04-30 | $1.10B | $4.73B | 24.89% |
| 2012-01-31 | $1.05B | $4.50B | 24.72% |
| 2011-10-31 | $1.01B | $4.32B | 25.59% |
| 2011-07-31 | $1.02B | $4.20B | 27.55% |
| 2011-04-30 | $0.89B | $3.96B | 26.67% |
| 2011-01-31 | $0.80B | $3.34B | 26.56% |
| 2010-10-31 | $0.68B | $3.24B | 24.26% |
| 2010-07-31 | $0.42B | $2.81B | 15.80% |
| 2010-04-30 | $0.19B | $2.63B | 7.54% |
| 2010-01-31 | $-0.02B | $2.60B | -0.64% |
| 2009-10-31 | $-0.03B | $2.51B | -1.24% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $29.217B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $227.162B | 27.40 |
| Boston Scientific (BSX) | United States | $140.689B | 37.90 |
| Stryker (SYK) | United States | $132.255B | 28.42 |
| EssilorLuxottica (ESLOY) | France | $128.431B | 0.00 |
| Medtronic (MDT) | Ireland | $105.938B | 15.47 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.424B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.151B | 26.20 |
| ResMed (RMD) | United States | $31.269B | 24.08 |
| GE HealthCare Technologies (GEHC) | United States | $28.556B | 13.89 |
| Terumo (TRUMY) | Japan | $28.160B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $22.192B | 15.85 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.373B | 12.24 |
| Insulet (PODD) | United States | $17.332B | 74.11 |
| Baxter (BAX) | United States | $14.818B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.356B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.938B | 17.06 |
| Bio-Rad Laboratories (BIO) | United States | $6.672B | 23.10 |
| Demant (WILYY) | Denmark | $6.644B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.977B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.455B | 9.89 |
| ICU Medical (ICUI) | United States | $3.400B | 29.07 |
| Haemonetics (HAE) | United States | $2.872B | 13.52 |
| Envista Holdings (NVST) | United States | $2.614B | 20.80 |
| GN Store Nord (GNNDY) | Denmark | $2.188B | 14.75 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 44.47 |
| QuidelOrtho (QDEL) | United States | $1.698B | 14.22 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.214B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.189B | 18.67 |
| AdaptHealth (AHCO) | United States | $1.051B | 10.12 |
| BioLife Solutions (BLFS) | United States | $1.041B | 0.00 |
| InMode (INMD) | Israel | $1.038B | 8.67 |
| Neogen (NEOG) | United States | $0.953B | 12.19 |
| Phibro Animal Health (PAHC) | United States | $0.700B | 10.74 |
| Evolus (EOLS) | United States | $0.686B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.649B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Owens & Minor (OMI) | United States | $0.535B | 4.56 |
| CeriBell (CBLL) | United States | $0.532B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.394B | 0.00 |
| Omeros (OMER) | United States | $0.394B | 0.00 |
| SNDL (SNDL) | Canada | $0.368B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.328B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.302B | 13.07 |
| Viemed Healthcare (VMD) | United States | $0.262B | 23.68 |
| Sanara MedTech (SMTI) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.261B | 15.65 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.251B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.250B | 44.40 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Biote (BTMD) | United States | $0.181B | 4.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.175B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.172B | 13.24 |
| Brainsway (BWAY) | Israel | $0.155B | 48.47 |
| Jin Medical (ZJYL) | China | $0.147B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.42 |
| Agape ATP (ATPC) | $0.094B | 0.00 | |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.086B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.083B | 0.00 |
| Exagen (XGN) | United States | $0.080B | 0.00 |
| MacroGenics (MGNX) | United States | $0.079B | 0.00 |
| Veru (VERU) | United States | $0.078B | 0.00 |
| Fonar (FONR) | United States | $0.076B | 10.65 |
| Zynex (ZYXI) | United States | $0.066B | 24.22 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| InterCure (INCR) | Israel | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 11.61 |
| Apyx Medical (APYX) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 51.50 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.010B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |